Domača stranBAX • NYSE
add
Baxter International Inc
Prejšnji trg. dan.
29,60 $
Dnevni razpon
29,05 $ - 29,50 $
Letni razpon
28,34 $ - 44,01 $
Tržna kapitalizacija
15,01 mrd. USD
Povprečni obseg
4,49 mio.
Razm. P/E
137,50
Dividendna donosnost
2,31 %
Primarna borza
NYSE
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 2,70 mrd. | 3,85 % |
Stroški poslovanja | 836,00 mio. | 4,50 % |
Čisti dohodek | 140,00 mio. | −94,42 % |
Čista dobičkovnost prihodkov | 5,19 | −94,62 % |
Earnings per share | 0,80 | 17,65 % |
EBITDA | 365,00 mio. | 1,11 % |
Efektivna davčna stopnja | 11,59 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 1,42 mrd. | −75,47 % |
Skupna sredstva | 26,68 mrd. | −12,98 % |
Skupne obveznosti | 18,73 mrd. | −16,70 % |
Celoten lastniški kapital | 7,94 mrd. | — |
Shares outstanding | 510,59 mio. | — |
Razmerje P/B | 1,92 | — |
Donosnost sredstev | 2,23 % | — |
Donosnost kapitala | 2,80 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 140,00 mio. | −94,42 % |
Denar iz dejavnosti | — | — |
Denar iz naložb | — | — |
Denar iz financiranja | — | — |
Neto sprememba denarnih sredstev | — | — |
Prost denarni tok | — | — |
Vizitka
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products. Baxter's BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine, and vaccines. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis. Wikipedia
Generalni direktor
Datum ustanovitve
1931
Sedež organizacije
Spletno mesto
Zaposleni
60.000
